John Dankert - Publications

Affiliations: 
University of Louisiana at Lafayette, Lafayette, LA, United States 
Area:
Microbiology Biology, Pharmacy

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Cárdenas W, Dankert JR, Jenkins JA. Flow cytometric analysis of crayfish haemocytes activated by lipopolysaccharides. Fish & Shellfish Immunology. 17: 223-33. PMID 15276602 DOI: 10.1016/j.fsi.2003.03.001  1
2001 Ocaña-Morgner C, Dankert JR. Induction of complement sensitivity in Escherichia coli by citric acid and low pH Journal of Applied Microbiology. 90: 771-778. PMID 11348438 DOI: 10.1046/j.1365-2672.2001.01305.x  1
2000 Cárdenas W, Jenkins JA, Dankert JR. A flow cytometric approach to the study of crustacean cellular immunity. Journal of Invertebrate Pathology. 76: 112-9. PMID 11023734 DOI: 10.1006/jipa.2000.4960  1
2000 Fredericks LP, Dankert JR. Antibacterial and hemolytic activity of the skin of the terrestrial salamander, Plethodon cinereus. The Journal of Experimental Zoology. 287: 340-5. PMID 10980492 DOI: 10.1002/1097-010X(20001001)287:5<340::AID-JEZ2>3.0.CO;2-9  1
2000 Cárdenas W, Dankert JR. Cresolase, catecholase and laccase activities in haemocytes of the red swamp crayfish Fish and Shellfish Immunology. 10: 33-46. PMID 10938721 DOI: 10.1006/fsim.1999.0228  1
1999 Deaton LE, Jordan PJ, Dankert JR. Phenoloxidase activity in the hemolymph of bivalve mollusks Journal of Shellfish Research. 18: 223-226.  1
1997 Cárdenas W, Dankert JR. Phenoloxidase specific activity in the red swamp crayfish Procambarus clarkii Fish and Shellfish Immunology. 7: 283-295.  1
1996 Gu X, Dankert JR. Isolation of the C9b fragment of human complement component C9 using urea in the absence of detergents Journal of Immunological Methods. 189: 37-45. PMID 8576578 DOI: 10.1016/0022-1759(95)00225-1  1
1995 Cargile JL, MacKay RJ, Dankert JR, Skelley L. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin American Journal of Veterinary Research. 56: 1451-1459. PMID 8585655  1
1995 Cargile JL, MacKay RJ, Dankert JR, Skelley L. Effects of tumor necrosis factor blockade on interleukin 6, lactate, thromboxane, and prostacyclin responses in miniature horses given endotoxin American Journal of Veterinary Research. 56: 1445-1450. PMID 8585654  1
1994 MacKay SLD, Dankert JR. Affinity of the C9 molecule for the C5b-8 complex compared with that for the complex containing C9 molecules Infection and Immunity. 62: 2800-2805. PMID 8005670  1
1994 Blanchard KP, Dankert JR. C9-mediated killing of bacterial cells by transferred C5b-8 complexes: Transferred C5b-9 complexes are nonbactericidal Infection and Immunity. 62: 4101-4106. PMID 7927662  1
1991 Dankert JR. Resistance of Escherichia coli to osmotically introduced complement component C9 Infection and Immunity. 59: 109-113. PMID 1987022  1
1991 Shiver JW, Dankert JR, Esser AF. Formation of ion-conducting channels by the membrane attack complex proteins of complement Biophysical Journal. 60: 761-769. PMID 1720679  1
1990 Watts MJ, Dankert JR, Morgan EP. Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids. The Biochemical Journal. 265: 471-7. PMID 2302178  1
1990 MacKay SLD, Dankert JR. Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites Journal of Immunology. 145: 3367-3371. PMID 2230122  1
1989 Dankert JR. Complement-mediated inhibition in complement-resistant Escherichia coli Journal of Immunology. 142: 1591-1595. PMID 2645364  1
1989 Watts MJ, Dankert JR, Morgan BP. Presence of a membrane attack complex inhibiting protein in biological fluids Biochemical Society Transactions. 17: 725-726.  1
1987 Dankert JR, Esser AF. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8 Biochemical Journal. 244: 393-399. PMID 3311029  1
1986 Dankert JR, Esser AF. Complement-mediated killing of Escherichia coli: Dissipation of membrane potential by a C9-derived peptide Biochemistry. 25: 1094-1100. PMID 3516214  1
1986 Shiver JW, Dankert JR, Donovan JJ, Esser AF. The ninth component of human complement (C9). Functional activity of the b fragment Journal of Biological Chemistry. 261: 9629-9636. PMID 2426252  1
1985 Dankert JR, Esser AF. Proteolytic modification of human complement protein C9: Loss of poly(C9) and circular lesion formation without impairment of function Proceedings of the National Academy of Sciences of the United States of America. 82: 2128-2132. PMID 3885222  1
1985 Dankert JR, Esser AF. Proteolytic and chemical modification of human complement protein C9: Loss of poly-C9 and circular lesion formation without impairment of function Federation Proceedings. 44.  1
1984 Esser AF, Shiver JW, Dankert JR, Donovan JD. The ninth component of complement: Functional activity of the B-domain Federation Proceedings. 43.  1
1983 Cramer WA, Dankert JR, Uratani Y. The membrane channel-forming bacteriocidal protein, colicin El Bba - Reviews On Biomembranes. 737: 173-193. PMID 6297581 DOI: 10.1016/0304-4157(83)90016-3  1
1980 Dankert J, Hammond SM, Cramer WA. Reversal by trypsin of the inhibition of active transport by colicin E1 Journal of Bacteriology. 143: 594-602. PMID 7009553  1
Show low-probability matches.